GemPharmatech and Charles River Laboratories Sign Exclusive Agreement to Distribute Next Generation NCG PortfolioJuly 26, 2022
GemPharmatech, Leading Provider of Genetically Engineered Mouse Models, Goes Public on Shanghai Stock ExchangeApril 25, 2022
